Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,414 | 18,078 | 14,776 | 4,541 | N/A |
| Marketable Securities | 53,817 | 26,349 | 16,615 | N/A | N/A |
| TOTAL | $61,878 | $45,077 | $31,965 | $4,585 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 3,367 | 880 | 756 | N/A | N/A |
| Investments And Advances | 0 | 1,500 | 0 | 0 | 0 |
| Other Non-Current Assets | 327 | 88 | 93 | 0 | 0 |
| TOTAL | $3,694 | $2,468 | $849 | $N/A | $N/A |
| Total Assets | $65,572 | $47,545 | $32,814 | $4,585 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,520 | 1,654 | 875 | 276 | 0 |
| Accrued Expenses | 7,654 | 4,120 | 1,211 | 399 | N/A |
| TOTAL | $10,174 | $5,774 | $2,086 | $675 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 73 | 70 | 7 | 87 | 0 |
| TOTAL | $73 | $70 | $7 | $87 | $N/A |
| Total Liabilities | $10,247 | $5,844 | $2,093 | $762 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9 | 6 | 5 | N/A | N/A |
| Common Shares | 24 | 18 | 13 | 2 | N/A |
| Retained earnings | -94,698 | -45,178 | -16,134 | -2,624 | N/A |
| Other shareholders' equity | -26 | 10 | -6 | 6,200 | 0 |
| TOTAL | $55,325 | $41,701 | $30,721 | $3,823 | $N/A |
| Total Liabilities And Equity | $65,572 | $47,545 | $32,814 | $4,585 | $0 |